What's new

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 15, Status: Authorised

Feb 13, 2025 - 16:37
 0
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Ozempic, semaglutide, Date of authorisation: 08/02/2018, Revision: 15, Status: Authorised
Read More

Tags:

Previous Article

Fierce Biotech Layoff Tracker 2025: Encoded trims 29% of team; Inventiva halves ...

Next Article

IRA domestic content bonus uncertain under Trump government – CEA

Related Posts

Human medicines European public assessment report (EPAR): Galvus, vildagliptin, Date of authorisation: 25/09/2007, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

Recommendations on eligibility to PRIME scheme - Adopte...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0